FDA 483 - Noxell Corporation - February 25, 2019

Coty Inc USA dba Noxell Corporation in Hunt Valley, MD, was cited for significant deficiencies in its manufacturing and quality control systems. The inspection revealed issues with incomplete batch production records, inadequate computer system controls allowing unauthorized data modification, and insufficient documentation of equipment cleaning verification. These observations indicate a lack of robust control over critical manufacturing processes and data integrity.